Ocuphire Pharma Inc.

09/30/2024 | Press release | Distributed by Public on 09/30/2024 06:06

Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology